Purpose | Dosage | Frequency | Administration |
---|---|---|---|
General Use | 300-600 mcg | 1-3x daily | Intranasal |
Cognitive Enhancement | 600-1200 mcg | 1-2x daily | Intranasal |
Neuroprotection | 1000-3000 mcg | 1-2x daily | Intranasal |
Research | 16.0 mcg/kg | As needed | Intranasal/Injectable |
Semax is a synthetic peptide drug developed in Russia. Key points:
Composed of the ACTH(4-7) fragment (Met-Glu-His-Phe) with an added Pro-Gly-Pro at the C-terminus
Also known as MEHFPGP, I5FAL2585H, Pro-Gly-Pro-ACTH(4-7), ACTH(4–7)PGP
Molecular formula: C39H55N11O11
Developed by the Institute of Molecular Genetics of the Russian Academy of Sciences
Approved for medical use in Russia for various neurological conditions
Stimulates neurotrophic factors, particularly Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF)
Impacts serotonin, dopamine, and enkephalin signaling
Modulates the expression of genes related to the immune system and vascular function
May act as an antagonist or partial agonist of melanocortin receptors (MC4 and MC5)
Inhibits enzymes involved in the degradation of enkephalins
Improves attention and short-term memory
Enhances learning and mental clarity
Protects against pressure-induced nerve damage in glaucoma
Shows protective effects against various neurotoxins
Potential benefits in stroke and ischemic conditions
May have antidepressant-like and anxiolytic-like effects
Enhances stress resilience
Affects the expression of cytokine genes
May have antiviral properties
Typical dose: 300-600 mcg per day
Often divided into 1-3 doses
Higher dose: 600-1200 mcg per day
Usually divided into 1-2 doses
Highest dose: 1000-3000 mcg per day
Often administered 1-2 times daily
If using lyophilized powder, reconstitute with bacteriostatic water
Use sterile equipment for mixing and administration
Calculate dosage based on concentration (e.g., 0.1% or 1% solution)
Tilt head back slightly
Insert dropper or spray nozzle into nostril
Administer prescribed dose
Allow solution to absorb through nasal mucosa
For research purposes, subcutaneous injection may also be used.
Nootropics (e.g., racetams)
Other peptides (e.g., Selank)
Semax is available through specialized pharmacies in Russia. For research purposes, it may be obtained from reputable peptide suppliers. Always ensure third-party testing and proper documentation.
No notable side effects reported in clinical trials
Safely administered in doses up to 12mg/daily for 10 consecutive days
Long-term safety data is limited
Headache
Nasal irritation
Slight anxiety at higher doses
Approved for medical use in Russia
Not approved by FDA or EMA for human use
Legal status varies by country
Often available as a research chemical, not for human consumption
Store in a cool, dry place away from direct light
Refrigerate after opening
Use within 30 days after opening
Do not freeze
Keep out of reach of children
Effects may be noticeable within 5-30 minutes of administration, with peak effects occurring within 2-4 hours.
While some studies have used Semax for up to 30 days, long-term safety data is limited. Consult a healthcare professional for extended use.
Some studies suggest improvements in attention and memory, but more research is needed to confirm these effects in healthy populations.
Semax shows promise as a neuroprotective and cognitive-enhancing peptide with a favorable safety profile. The typical dosage range of 300-3000 mcg per day, depending on the application, appears effective for most research purposes. However, its use should be approached cautiously due to limited long-term safety data and varying legal status worldwide. As with any experimental compound, thorough research and professional consultation are essential before use.
Gusev EI, et al. (2005). Semax in prevention of disease progress and development of exacerbations in patients with cerebrovascular insufficiency. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 105(2), 35-40.
Dolotov OV, et al. (2006). Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Research, 1117(1), 54-60.
Medvedeva EV, et al. (2014). The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis. BMC Genomics, 15(1), 228.
Manchenko DM, et al. (2010). The effects of semax and its Pro-Gly-Pro fragment on calcium homeostasis of neurons and their survival under conditions of glutamate toxicity. Russian Journal of Bioorganic Chemistry, 36(2), 268-274.
Asmarin IP, et al. (1997). A nootropic adrenocorticotropin analog 4-10-semax (15 years experience in its design and study). Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova, 47(2), 420-430.
Disclaimer
Peptideresearcher.com contains information about products intended for research and laboratory use only, unless otherwise explicitly stated. All content is for educational purposes and is not meant to substitute for professional medical advice. Peptideresearcher.com strives to ensure that all information presented is accurate and complies with national and international standards, but it is not guaranteed. The content provided is not intended to diagnose, treat, cure, or prevent any disease or condition.
Peptideresearcher.com does not offer medical diagnoses or prescriptions. Any product information shared is solely for research purposes and should be used by qualified professionals only. We advise all users to consult with a healthcare professional before using any peptides, supplements, or medications mentioned on this site. All opinions expressed are those of the individual authors and may not reflect the opinions of Peptideresearcher.com.
Copyright 2024 - Peptide Researcher
Your access to Peptideresearcher.com is subject to our Terms of Use